|
|
商品名 |
|
|
商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。
|
Eberelbin |
伊朗 |
Eunexon |
秘鲁 |
Eurovinorelbin |
德国 |
Navelbin |
匈牙利 |
Navelbine |
丹麦, 伊朗, 冰岛, 卢森堡, 印度, 哥伦比亚, 土耳其, 埃及, 墨西哥, 奥地利, 希腊, 德国, 意大利, 挪威, 新西蘭, 智利, 比利时, 沙特阿拉伯, 法国, 波兰, 澳大利亚, 爱尔兰, 瑞典, 瑞士, 秘鲁, 突尼斯, 罗马尼亚, 美国, 芬兰, 英国, 葡萄牙, 西班牙, 阿根廷, 阿联酋, 马来西亚 |
Navildez |
墨西哥 |
Navin |
德国 |
Navirel |
德国, 挪威, 瑞典 |
Okabine |
秘鲁 |
Relbinalur |
瑞典 |
Renovel |
土耳其 |
Setroxin |
墨西哥 |
Sulcoline |
阿根廷 |
Tarckorel |
墨西哥, 秘鲁 |
Vieby |
墨西哥 |
Viessia |
哥伦比亚, 墨西哥, 委内瑞拉 |
Vilne |
厄瓜多尔, 秘鲁, 阿根廷 |
Vinarine |
委内瑞拉, 秘鲁, 阿根廷 |
Vinelbine |
马来西亚 |
Vinilex |
墨西哥 |
Vinkebir |
秘鲁, 阿根廷 |
Vinobina |
哥伦比亚 |
Vinobur |
瑞典 |
Vinolbin |
德国 |
Vinorel |
秘鲁, 阿根廷 |
Vinorelbin |
冰岛, 厄瓜多尔, 奥地利, 德国, 挪威, 比利时, 瑞典, 瑞士, 罗马尼亚 |
Vinorelbina |
厄瓜多尔, 哥伦比亚, 墨西哥, 秘鲁, 罗马尼亚, 西班牙 |
Vinorelbine |
伊朗, 加拿大, 新西蘭, 比利时, 瑞士, 美国, 英国, 阿根廷 |
Vinorgen |
智利, 秘鲁 |
Zinavin |
哥伦比亚 |
|
|
|
|
引用文献 : Vinorelbine tartrate |
|
|
种类 |
出版物 |
84 |
文献 |
Trissel LA, Martinez JF. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Am J Hosp Pharm 1994 ; 51: 495-499. |
144 |
文献 |
Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML. Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags. Int J Pharm 1991 ; 77: 279-285. |
182 |
文献 |
Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60. |
244 |
文献 |
Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913. |
251 |
文献 |
Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713. |
307 |
文献 |
Trissel LA, Martinez JF. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1792-1799. |
905 |
文献 |
Trissel LA, Martinez JF. Screening teniposide for Y-site physical incompatibilities. Hosp Pharm 1994 ; 29: 1010-1017. |
921 |
文献 |
Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292. |
1070 |
文献 |
Balthasar JP. Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium. Am J Health-Syst Pharm 1999 ; 56: 1891. |
1413 |
文献 |
Lieu CL, Chin A, Gill MA. Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature. Int J Pharm Compound 1999 ; 3: 67-68. |
1423 |
文献 |
Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518. |
1501 |
文献 |
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121. |
1520 |
实验室 |
Etude de stabilité des médicaments en Ecoflac® B Braun 2001 |
1625 |
文献 |
Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321. |
1662 |
文献 |
Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37. |
2260 |
实验室 |
Stability of vinorelbin "Ebewe" infusion solutions. Ebewe Pharma 2007 |
3128 |
实验室 |
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013 |
3474 |
实验室 |
Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009 |
3595 |
实验室 |
Aciclovir - Summary of Product Characteristics Hospira 2009 |
3641 |
实验室 |
Vinorelbine (Navelbine®) - Summary of Product Characteristics Pierre Fabre 2011 |
3644 |
实验室 |
Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010 |
3838 |
实验室 |
Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007 |
4471 |
实验室 |
Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019 |
|
|